Xailin^® Ectoine: A force against external allergens: soothe, protect and hydrate your eyes all year round.

VISUfarma are launching Xailin^® Ectoine eye drops: for the symptomatic relief of red, itchy, watery and burning eyes caused by year-round allergy-related irritation and dryness, in a preservative and phosphate free formulation.

Dry Eye

Dry eye is a multifactorial disease of the ocular surface characterised by loss of homeostasis of the ocular surface, accompanied by ocular symptoms, in which tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles.² It can be attributed to a variety of factors, including dry, heated or air-conditioned environments, auto-immune diseases (such as Sjogren Syndrome, rheumatoid arthritis, and lupus), and the prolonged exposure to screens including smart phones and laptops.³

The prevalence of dry eye disease is difficult to estimate as there is no defined diagnostic test. Although it can affect people of any age, it is more prevalent in women and those over the age of 50.^3,4 It is reported that 33% of people aged 65 years or over have dry eye disease, though this is likely to be an underestimation of the true prevalence.⁴

Perennial Allergies

Allergens including seasonal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis

(PAC) are the most common forms of ocular allergy.⁵

SAC and PAC affects up to 40% of the population, and can significantly impact an individual’s quality of life (QoL).⁵ Having a healthy tear film can help to remove allergens from the ocular surface.⁶

Introducing Xailin^® Ectoine Eye Drops 

Xailin^® Ectoine: A force against external allergens: soothe, protect and hydrate your eyes all year round. A unique combination of Hyaluronic Acid 0.1%, Ectoine 2%, Fucoidan 0.1% and Perilla Extract 0.1%, Xailin^® Ectoine provides symptomatic relief of red, itchy, watery and burning eyes caused by year-round allergy-related irritation and dryness.¹

Xailin^® Ectoine eye drops is preservative & phosphate free.¹

A Natural and Effective Alternative for Allergic Conjunctivitis
Ectoine’s membrane-stabilising, anti-inflammatory properties have demonstrated effects comparable to pharmacological agents. Fucoidan and Perilla Extract add further antioxidant and anti-allergenic benefits, while HA ensures optimal moisture retention and ocular surface repair.^7,8

Environmentally Conscious
In line with VISUfarma UK’s commitment to sustainability, we pledge to offset all usage of Xailin^® Ectoine in our mission as a Carbon Net Zero and Plastic Neutral company.

Benefits of Xailin^® Ectoine:

• A unique combination of 4 ingredients to provide year-round protection against allergy and inflammation.¹
• Long-lasting protection: the power of an anti-histamine with the comfort of a drop.¹
• Soothes inflammation and allergic reactions.¹
• Effectively moisturises.¹
• Non-drowsy, preservative and phosphate free formula.¹
• Daily relief with just 3 drops.¹
• For daily, year-round use.¹
• Reduces allergen inflammation.¹
• Mucoadhesive + viscoeslastic: enhances tear film stability.¹
• Promotes epithelial repair.¹
• Protects cells from external allergens.¹
• Remains sterile for up to 3 months after opening.¹

Relief that lasts. Year-round protection for your eyes.

Xailin^® Ectoine is available in a 10ml multidose bottle and is available from all major optical wholesalers now. For more information, please call VISUfarma on 0113 4680661 or e-mail UKcustomerservices@visufarma.com 

About VISUfarma

VISUfarma is a pan-European ophthalmic specialty pharmaceutical company with a clear mission: to bring global innovation to European eye health. Our promise is to offer high quality products and to spread eye health innovation and knowledge, from across the globe, throughout Europe.

For inquiries, please contact our UK Customer Services team at UKcustomerservices@visufarma.com    

References

1. Xailin^® Ectoine Instructions for Use (IFU).
2. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017 Jul;15(3):276-283.
3. NHS https://www.nhs.uk/conditions/dry-eyes/ last accessed June 2025.
4. NICE https://www.nice.org.uk/guidance/ta369/documents/dry-eye-disease-ciclosporin-final-scope2 last accessed June 2025.
5. La Rosa, M. et al. Allergic conjunctivitis: a comprehensive review of the literature. Italian Journal of Pediatrics 2013, 39:18.
6. Guarise C, et al. The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model. J Mechanical Behavior of biomed Materials. 2023;143:105908.
7. Bilstein, A. et al. Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface. Hindawi BioMed Research International. Volume 2021, Article ID 8885032, 16 pages.
8. Wekhauser, N. et al. Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray. Hindawi Publishing Corporation Journal of Allergy. Volume 2014, Article ID 176597, 13 pages.